GBLB 📈 Groep Brussel Lambert - Overview

Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003797140

GBLB: Industrial, Consumer Goods, Business Services

Groupe Bruxelles Lambert SA (GBL) is a Belgian investment holding company that has a diversified portfolio of industrial, consumer goods, and business service companies operating across various sectors globally.

GBL's portfolio is divided into seven distinct segments, each with its own unique focus. The Holding segment serves as the parent company, overseeing the overall strategy and direction of the group. Imerys is a leading global supplier of mineral-based specialty solutions, while Webhelp is a business process outsourcing company that provides customer experience and business process solutions. Canyon is a renowned bicycle manufacturer, and Affidea is a healthcare services provider that operates diagnostic imaging centers and cancer treatment facilities. Sanoptis is a healthcare company that specializes in eye care and hearing aid solutions. Lastly, GBL Capital and Sienna Investment Managers are the group's investment management arms, responsible for managing the company's assets and investments.

With a rich history dating back to 1902, GBL has established itself as a prominent player in the global investment landscape. Headquartered in Brussels, Belgium, the company has expanded its reach to Europe, North America, and other international markets, solidifying its position as a key player in the investment industry.

For more information about Groupe Bruxelles Lambert SA, please visit their website at https://www.gbl.be.

Additional Sources for GBLB Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

GBLB Stock Overview

Market Cap in USD 8,689m
Sector Financial Services
Industry Asset Management
GiC Industry Financial Services
TER 0.00%
IPO / Inception

GBLB Stock Ratings

Growth 5y -22.6%
Fundamental 53.4%
Dividend 46.8%
Rel. Performance Sector -4.57
Analysts -
Fair Price Momentum 62.44 EUR
Fair Price DCF 75.37 EUR

GBLB Dividends

Dividend Yield 12m 4.22%
Yield on Cost 5y 3.54%
Annual Growth 5y -2.18%
Payout Consistency 98.77%

GBLB Growth Ratios

Growth Correlation 3m -72.3%
Growth Correlation 12m -1.2%
Growth Correlation 5y -25.3%
CAGR 5y -3.41%
CAGR/Mean DD 5y -0.19
Sharpe Ratio 12m -0.85
Alpha -31.10
Beta 0.64
Volatility 13.98%
Current Volume 80.2k
Average Volume 20d 115.6k
What is the price of GBLB stocks?
As of December 04, 2024, the stock is trading at EUR 65.15 with a total of 80,183 shares traded.
Over the past week, the price has changed by +0.39%, over one month by -4.54%, over three months by -4.47% and over the past year by -6.51%.
Is Groep Brussel Lambert a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Groep Brussel Lambert (BR:GBLB) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.35 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GBLB as of December 2024 is 62.44. This means that GBLB is currently overvalued and has a potential downside of -4.16%.
Is GBLB a buy, sell or hold?
Groep Brussel Lambert has no consensus analysts rating.
What are the forecast for GBLB stock price target?
According to ValueRays Forecast Model, GBLB Groep Brussel Lambert will be worth about 67.4 in December 2025. The stock is currently trading at 65.15. This means that the stock has a potential upside of +3.5%.
Issuer Forecast Upside
Wallstreet Target Price 89.8 37.9%
Analysts Target Price - -
ValueRay Target Price 67.4 3.5%